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4 Institute for Biological Research “Siniša Stanković”—National Institute of Republic of Serbia, University
of Belgrade, Bulevar Despota Stefana 142, 11000 Belgrade, Serbia; marina.kostic@ibiss.bg.ac.rs (M.K.);
mris@ibiss.bg.ac.rs (M.S.)
* Correspondence: spetropoulos@uth.gr (S.A.P.); lillian@ipb.pt (L.B.); Tel.: +30-2421-093-196 (S.A.P.);
+351-273330904 (L.B.)
Abstract: Hydroethanolic extracts of cardoon petioles collected at sixteen growth stages (P1–P16)
were characterized in terms of their phenolic composition and bioactive potential (antioxidant,
cytotoxic, anti-inflammatory, and antimicrobial activities). Fifteen phenolic compounds were tenta-
tively identified (i.e., ten phenolic acids and five flavonoid glycosides); the main compounds were
5-O-caffeoylquinic and 1,5-di-O-caffeoylquinic acids. Samples collected at early maturity (P1–P4) pre-
sented a weak positive correlation between the higher content in polyphenols (P3: 101-mg/g extract)
and better inhibition capacity against thiobarbituric acid reactive substance formation (TBARS; P3:
IC50 = 5.0 µg/mL). Samples at intermediate maturation stages (P9) presented higher cytotoxic and
anti-inflammatory potential. Moreover, immature petioles showed greater antihemolytic (OxHLIA;
P4: IC50 = 65 and 180 µg/mL for ∆t of 60 and 120 min, respectively) and antibacterial activity.
The antifungal activity varied depending on the maturation stage and the fungi strain. In conclusion,
the maturation stage may greatly affect the polyphenols composition and content and the bioactive
potential of cardoon petioles.
Keywords: cardoon; phenolic composition; antioxidant activity; seasonal changes; anti-inflammatory
activity; oxidative hemolysis; antimicrobial properties
1. Introduction
Plant species, including those of the Asteraceae family, contain a massive variety of
compounds with high bioactive potential, being considered as the principal sources of new
healing agents [1,2]. In particular, representatives of the Asteraceae family have already
been characterized by the presence of specific phenolic acids and flavonoids [3]. Despite
the significant contributions that compounds of natural origin have made to the discovery
of potent drugs, with enormous structural complexity and diversity, their isolation and
identification remain an important and rewarding area of study, as new compounds
continue to be identified. Plant species remain an excellent source for the discovery of
biomolecules with high pharmacological potential [4–6]. Plant secondary metabolites show
antioxidant, anti-inflammatory, cytotoxic and hepatotoxic, and antimicrobial activities,
and several studies are developing nowadays due to a huge plant biodiversity and their
secondary metabolites [7,8].
Antioxidants 2021, 10, 1907. https://doi.org/10.3390/antiox10121907 https://www.mdpi.com/journal/antioxidants
Antioxidants 2021, 10, 1907 2 of 19
Cynara cardunculus L. is a species that belongs to the Asteraceae family, commonly des-
ignated as cardoon, and comprises three botanical varieties: var. altilis DC, var. scolymus (L.)
Fiori, and var. sylvestris (Lamk) Fiori. This species is widely used in Mediterranean cuisine
and folk medicine due to its nutritional composition, choleretic, hypocholesterolemic, and
diuretic properties and effectiveness in the treatment of hepatic diseases [9,10]. Cardoon
is also an important source of components such as fiber, carbohydrates, inulin, minerals,
and polyphenolic compounds [2,10,11]. Besides its nutritional and phytochemical interest,
this species is used in a wide variety of industrial applications. For example, it can be
used as vegetable rennet in the production of some protected designation of origin (PDO)
cheeses [12,13], paper pulp [14], food oil [15], and bioenergy [16,17], as well as animal
forage [18,19]. The multifaceted industrial applications of cardoon are fundamental for its
economic valorization and exploitation [17]. However, industrial processing generates a
large amount of wasted material, which can be an important source of biologically active
compounds [17,20]. Since several parameters influence the chemical composition and
bioactive properties of the species (i.e., environmental conditions, harvest time, genetic
variability, and plant tissue) [10,21,22], the proper exploration and characterization of the
species and all its constituents are extremely important and of great interest.
The harvesting and maturity stages are essential for the chemical composition of
natural products obtained from plant tissues, as already reported in the literature for
various plant species, e.g., flowers and leaves of Brassica rapa [23], heads and bracts of
cardoon [22,24], leaves of Cichorium spinosum [25], okra fruit [26], etc. Therefore, the present
work aims to evaluate the influence of the harvest date on the phenolic compound’s
composition and the in vitro biological properties of cardoon petioles collected throughout
the growth cycle (e.g., start of vegetative growth to senescence). The main objectives of
the study were: (a) to value cardoon petioles through a more complete characterization of
their properties and chemical composition, (b) to determine how the chemical composition
and bioactive properties diverge throughout the plant’s growth cycle, and (c) to evaluate
the potential to stimulate their exploitation and economic valorization, since it is still an
underexplored vegetable tissue.
2. Materials and Methods
2.1. Plant Material
Petioles of Cynara cardunculus var. altilis DC cv. Bianco Avorio (Fratelli Ingegnoli Spa,
Milano, Italy) were harvested during the growing period of 2017 to 2018 in Central Greece
at the experimental field of the University of Thessaly in Velestino (22.756 E, 39.396 N) [22].
Petioles were collected at sixteen harvesting dates according to the principal growth stages
(PGS) defined by the Biologische Bundesanstalt, Bundessortenamt, CHemische Industrie
(BBCH) scale, comprising the stages between PSG 1 and PSG 9 [27]. Samples P1, P2, and P3
were collected in September, October, and the start of November (all PSG 1), respectively;
P4 was collected at the end of November (PSG 2); samples P5, P6, P7, and P8 were collected
at the beginning of January (PSG 3), February (PSG 3/4), March (PSG 4), and April (PSG
4/5), respectively; sample P9 was collected at the end of April (PSG 5); samples P10 and
P11 were collected at the beginning (PSG 5/6) and at the end of May (PSG 6); P12 was
collected at the beginning of June (PSG 6/7); samples P13 and P14 were collected at the
beginning (PSG 7/8) and at the end of July (PSG 8); and samples P15 and P16 were collected
at the beginning (PSG 8/9) and at the end of August (PSG 9). At each harvesting date, one
leaf per plant from 15 individual plants (n = 15) was collected based on leaf phenology
and according to the principal growth stages defined by Archontoulis et al. [27]. The
morphology of leaves at different harvesting stages is presented in Figure 1. For each
harvesting date, all the collected leaves were pooled into a batch sample. Each pooled
sample consisted of at least 500 g of fresh tissue.
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Figure 1. Leaf morphology at different harvesting stages (Sample P 1–16). Photo credits: Petropoulos S.A. (personal record).
After collection, the leaves were thoroughly cleaned with distilled water, then cut
into small pieces and stored in air-sealed plastic bags at deep-freezing conditions. All
the samples were freeze-dried (Sublimator model EKS, Christian Zirbus Co., Brunswick,
Germany) and reduced with a domestic blender to a fine powder (~20 mesh). The ground
samples were stored in air-sealed bags in a deep freezer (−80 ◦C) and under protection
from light until further analysis.
2.2. Extraction Procedure
Petiole samples (1.5 g of fine powder) were extracted with a mixture (EtOH/H2O,
80:20, v/v; 30 mL) under dynamic stirring (150 rpm) for 1 h at room temperature and
according to the procedure previously described [22]. The obtained solutions were filtered
through Whatman No. 4 filter paper and concentrated at 40 ◦C under reduced pressure
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(rotary evaporator Büchi R-210, Flawil, Switzerland). The aqueous phase was frozen and
lyophilized (FreeZone 4.5, Labconco, Kansas City, MO, USA). The extraction yield of each
sample, referring to the concentration of mg of compound/100 g of petioles, was also
calculated and expressed in percentage (%).
2.3. Phenolic Compound Identification and Quantification
The obtained petiole extracts were redissolved in EtOH:H2O (80:20, v/v) to obtain
a final concentration of 10 mg/mL and filtered using 0.22-µm nylon syringe filters. The
polyphenolic composition was analyzed by high-performance liquid chromatography
coupled to a diode array detector and electrospray ionization mass spectrometry (HPLC-
DAD-ESI/MS), according to the chromatographic conditions described [28]. The chromato-
graphic separation was performed using a Waters Spherisorb S3 ODS-2C18 (3 µm, 4.6 mm
× 150 mm, Waters, Milford, MA, USA) column at 35 ◦C and an isocratic elution gradient
between 0.1% formic acid in water and 100% acetonitrile. The DAD was programmed at
280 nm, 330 nm, and 370 nm as the preferred wavelengths for the double online detection
of protocatechuic acid, hydroxycinnamic acids, and flavonoids, respectively. A Linear Ion
Trap LTQ XL mass spectrometer (ThermoFinnigan, San Jose, CA, USA) equipped with an ESI
source was used for MS detection in the negative mode, using nitrogen as the sheath gas (50 psi)
and operating with a spray voltage of 5 kV, a source temperature of 325 ◦C, a capillary voltage of
−20 V, and a collision energy used of 35 (arbitrary units). The data acquisition was carried out
with the Xcalibur®data system (ThermoFinnigan, San Jose, CA, USA).
The tentative identification of the phenolic compounds in the studied cardoon petioles
was performed by comparison of the chromatographic data (retention times, UV–Vis, and
mass spectra) with commercial standards and literature information. The quantification
was performed through the determination of the peak areas. Seven-level calibration curves
(EtOH:H2O, 80:20, v/v, linearity 80–1.25 µg/mL) prepared for each available commercial
standard (Extrasynthèse, Genay, France) were used: compounds number 1, 3, 4, 5, 7, 10,
11, 12, and 15—chlorogenic acid (y = 168,823x + 161,172, R2 = 0.9999, LOD 0.20 µg/mL,
LOQ 0.68 µg/mL); compound number 2—protocatechuic acid (y = 214,168x + 27,102,
R2 = 0.9999, LOD 0.14 µg/mL, LOQ 0.64 µg/mL); and compounds number 6, 8, 9, 13, and
14—quercetin-3-O-glucoside (y = 34,843x − 160,173, R2 = 0.9998, LOD 0.21 µg/mL, LOQ
0.71 µg/mL). The results were expressed as mg equivalents of the corresponding standard
used for quantification per g of extract; however, for simplification purposes, the results
will be expressed in mg per g of extract.
2.4. Evaluation of the Bioactive Potential
2.4.1. Antioxidant Activity
The antioxidant potential of cardoon petioles was evaluated through two cell-based
methodologies: the thiobarbituric acid reactive substances (TBARS) formation and the
oxidative hemolysis (OxHLIA) inhibition assays. Trolox (Fisher Scientific, Lisbon, Portugal),
a synthetic antioxidant, was used as a positive control.
The TBARS assay was performed according to the procedure previously described [10].
The cardoon petiole extracts were redissolved in water to obtain a solution of 5 mg/mL,
which was further diluted in order to obtain the concentration range to be tested (0.0012–
1.25 mg/mL). The results were expressed as the concentration of extract (IC50 µg/mL)
responsible for 50% of the oxidation process inhibition.
For the OxHLIA assay, it measured the capacity of the extracts to inhibit oxidative
hemolysis using erythrocytes isolated from sheep blood, following the procedure previ-
ously described [29]. The results were expressed as the extract concentrations (IC50 µg/mL)
necessary to ensure 50% of the erythrocyte population integrity after ∆t of 60 and 120 min.
Phosphate-buffered saline (PBS; pH 7.4) was used as a negative control.
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2.4.2. Anti-Inflammatory Activity
The anti-inflammatory activity was determined through the measurement of the petiole
extract’s capacity to inhibit the proinflammatory nitric oxide (NO) production in a murine
macrophage cell line (RAW 264.7) induced by the lipopolysaccharide (LPS) (Sigma-Aldrich,
St. Louis, MO, USA) according to the procedure previously described [29]. The cardoon
petiole extracts were redissolved in water to obtain a stock solution with a concentration of
8 mg/mL that was further diluted to obtain the tested concentrations (6.25–400 µg/mL). The
commercial anti-inflammatory agent dexamethasone (Sigma-Aldrich, St. Louis, MO, USA) was
used as a positive control, and cells without LPS were considered as the negative control. The
results were expressed as the extract concentrations (IC50 µg/mL) responsible for inhibiting
the production of the inflammatory process mediator (NO) by 50%.
2.4.3. Cytotoxic and Hepatotoxic Activities
The cytotoxic and hepatotoxic potential of cardoon petiole extracts were measured us-
ing the sulforhodamine B assay according to the procedure previously described [10].
The extracts were redissolved in water, obtaining a stock solution with a concentra-
tion of 8 mg/mL that was further diluted to obtain the range of concentrations tested
(6.25–400 µg/mL). The cytotoxic activity was measured using four human tumor cell lines:
breast carcinoma (MCF-7), non-small cell lung cancer (NCI-H460), cervical carcinoma
(HeLa), and hepatocellular carcinoma (HepG2), all acquired from the Leibniz-Institute
DSMZ–German Collection of Microorganisms and Cell Cultures GmbH (Braunschweig,
Germany). The hepatotoxic activity was evaluated in a nontumor porcine liver primary
culture (PLP2). Ellipticine (Sigma-Aldrich, St. Louis, MO, USA) was used as a positive
control, and cell suspensions without any sample were used as a negative control. The
results were expressed as the extract concentrations (GI50 µg/mL) responsible for inhibiting
cell proliferation by 50%.
2.4.4. Antimicrobial Activity
Cardoon petiole extracts were redissolved in 5% of dimethyl sulfoxide (DMSO) (Sigma-
Aldrich, St. Louis, MO, USA) and diluted to obtain the range of concentrations tested. The
antibacterial activity and antifungal potential were evaluated according to the procedure
previously described [30]. The antibacterial activity was evaluated against Gram-positive
Bacillus cereus (food isolate), Staphylococcus aureus (ATCC 11632), and Listeria monocytogenes
(NCTC 7973) and the Gram-negative Enterobacter cloacae (human isolate), Escherichia coli (ATCC
35210), and Salmonella Typhimurium (ATCC 13311). The evaluation of the antifungal potential
was assessed against Aspergillus fumigatus (human isolate), Aspergillus versicolor (ATCC 11730),
Aspergillus niger (ATCC 6275), Penicillium funiculosum (ATCC 36839), Penicillium ochrochloron
(ATCC 9112), and Penicillium aurantiogriseum (Penicillium verrucosum var. cyclopium; food
isolate). All the microorganisms are deposited at Mycological Laboratory, Department of
Plant Physiology, Institute for Biological Research “Siniša Stanković”, National Institute of
Republic of Serbia, University of Belgrade, Serbia. Commercial antibiotics ampicillin and
streptomycin were used as the positive controls with the antifungal ketoconazole (all acquired
from Sigma-Aldrich, St. Louis, MO, USA). A solution of 5% DMSO was used as the negative
control. The results were presented as the minimal inhibitory (MIC), bactericidal (MBC), or
fungicidal (MFC) concentration (mg/mL).
2.5. Statistical Analysis
All the assays were performed in triplicate, while three extracts were obtained from
each sample. The results were presented as the mean value ± standard deviation (except
for the antimicrobial activity), both calculated using Microsoft Excel (Microsoft Corporation,
Redmond, WA, USA). The obtained results were analyzed through SPSS Statistics software
(IBM SPSS Statistics for Mac OS, Version 26.0; IBM Corp., Armonk, NY, USA). To determine
if there were significant differences between samples, an analysis of variance (ANOVA)
was also applied, while a comparison of the means was performed with the Student’s t-test
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(α = 0.05). Furthermore, a Pearson’s correlation analysis between the bioactivities and all
the sum contents of the analyzed compounds (total phenolic acid, total flavonoids, and
total phenolic compounds) was carried out, with a 95% confidence level.
A principal component analysis (PCA) was also performed in order to examine the
contribution of each variable to the total diversity and classify the studied maturation stages
according to their chemical compositions by using the statistical software Statgraphics
5.1.plus (Statpoint Technologies, Inc., Warrenton, VA, USA).
3. Results and Discussion
3.1. Phenolic Compounds Composition
The results regarding the phenolic compound compositions, peak characteristics, and
their tentative identifications are presented in Table 1. The quantification of each individual
compound is presented in Table 2, as is the extraction yield (referring to the concentration
of mg of compound/100 g of petioles but expressed in percentage) of each sample. In
Figure 2 are presented the main phenolic acids and flavonoids found in the samples studied
and, in the Supplementary Materials (SM1), the exemplified phenolic profiles of the sixteen
samples of cardoon studied recorded at 280 nm. The phenolic compounds were tentatively
identified according to their retention time (Rt), the wavelength of maximum absorbance
(λmax), deprotonated ion ([M-H]−), and fragmentation pattern (MS2). A total of fifteen
compounds were tentatively identified in cardoon petioles, including ten phenolic acid
derivatives (peaks 1, 2, 3, 4, 5, 7, 10, 11, 12, and 15) and five flavonoid glycosides (peaks 6,
8, 9, 13, and 14).
Table 1. Phenolic compounds tentatively identified in the hydroethanolic extracts of cardoon petioles.
Peak Rt (min) λmax (nm) [M-H]− (m/z) MS2 (m/z) Tentative Identification
1 4.18 321 353 191 (100), 179 (33), 173 (5), 135(5) 3-O-Caffeoylquinic acid
2 6.14 266 153 109 (100) Protocatechuic acid
3 6.52 321 353 173 (100), 179 (11), 191 (10), 161(5), 135 (5) 4-O-Caffeoylquinic acid
4 6.63 326 353 191 (100), 179 (7), 173 (5), 135 (5) cis-5-O-Caffeoylquinic acid
5 7.10 326 353 191 (100), 179 (7), 173 (5), 135 (5) trans-5-O-Caffeoylquinicacid
6 15.97 285/sh324 463 287 (100) Eriodictyol-O-hexuronoside
7 16.69 322 515 353 (100), 335 (25), 191 (62), 179(15) 1,3-di-O-caffeoylquinic acid
8 18.61 266/343 461 285 (100) Luteolin-O-hexuronosidederivative I
9 18.86 267/343 461 285 (100) Luteolin-O-hexuronosidederivative II
10 19.01 334 515 353 (100), 179 (10), 173 (29), 353(10), 191 (10), 135 (8), 161 (5) O-Dicaffeyolquinic acid
11 20.39 324 515 353 (100), 191 (12), 335 (10) 1,5-di-O-cafffeoylquinic acid
12 22.66 329 515
353 (100), 335 (5), 229 (2), 255 (2),
203 (2), 191 (75),
179 (13), 173 (5, MS3 base peak)
3,4-di-O-cafffeoylquinic acid
13 23.69 268/332 533 489 (100), 285 (20) Luteolin-O-malonylhexoside derivative I








Protocatechuic acid (peak 2) was identified by comparing the retention time and
the maximum UV spectra with the chromatographic characteristics of the corresponding
available standard compound. The caffeoylquinic and dicaffeoylquinic acids (peaks 1, 3,
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4, 5, 7, 10, 11, 12, and 15) were identified according to the hierarchical keys proposed by
Clifford et al. [31] and Clifford, Susan, and Nikolai [32], based on the deprotonated ion
([M-H]− at m/z 353 and 515, respectively) and characteristic intensity of the fragment
ions produced. The MSn spectra for the dicaffeoylquinic acids are provided in the Sup-
plementary Materials (SM2). Regarding the flavonoids, peak 6 was tentatively identified
as eriodictyol-O-hexuronoside, presenting a deprotonated ion [M-H]− at m/z 463 and a
unique MS2 fragment at m/z 287 (eriodictyol aglycone), corresponding to the loss of 176 u
of a hexuronoside unit. Finally, two O-glycosylated luteolin derivatives were tentatively
identified as luteolin-O-hexuronoside derivatives I and II (peaks 8 and 9, respectively),
since both presented the same deprotonated ion [M-H]− at m/z 461 and a unique MS2 frag-
ment at m/z 285 (luteolin aglycone), corresponding to the loss of 176 u of a hexuronoside
unit. The same behavior was observed for peaks 13 and 14, luteolin-O-malonyl hexoside
derivatives I and II, respectively, presenting a deprotonated ion [M-H]− at m/z 533 and
MS2 fragments at m/z 489 and 447 (44 u + 42 u, malonyl group) and m/z 285 (162 u, a
hexosyl moiety).
Peaks 1 and 3 (3-O-caffeoylquinic and 4-O-caffeoylquinic acids) have been previ-
ously described in cardoons [20,21,33,34]. Similarly, peaks 4 and 5 (cis-5-O-caffeoylquinic
and trans-5-O-caffeoylquinic acids) were previously identified in different cardoon tis-
sues [10,22], peak 6 (Eriodictyol-O-hexuronoside) in cardoon inflorescences [21] and
bracts [10], and peaks 8 and 9 in cardoon heads [22] and bracts [10]. Peaks 13 and 14
have been previously described in cardoon bracts [10] and inflorescences [21]. Different iso-
mers of dicaffeoylquinic acids have also been reported in different cardoon tissues, such as
trans-3,4-O-dicaffeoylquinic, cis-3,5-di-O-caffeoylquinic, and trans-3,5-di-O-caffeoylquinic
acids [33], as also in cardoon leaf midribs and petioles (trans-4,5-di-O-caffeoylquinic
acid) [33]. Finally, peak 2 was tentatively identified as protocatechuic acid based on
the chromatographic information described by Graça et al. [35] and its previous detec-
tion in the bracts of Cynara cardunculus var. scolymus [36]. To the best of our knowledge,
protocatechuic acid has not yet been reported in the altilis variety.
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Table 2. Content of the phenolic compounds determined in the hydroethanolic extracts of cardoon petioles.
Peak
Quantification (mg Equivalents of the Corresponding Standard Used for Quantification Per g of Extract)
P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 P12 P13 P14 P15 P16
1 n.d. n.d. n.d. 1.22 ± 0.03 a 0.83 ± 0.01 b 0.52 ± 0.01 ef 0.48 ± 0.02 g 0.35 ± 0.01 i 0.51 ± 0.01 f 0.568 ± 0.002 c 0.32 ± 0.01 j 0.42 ± 0.02 h
0.559 ± 0.004
cd 0.54 ± 0.01 de n.d. n.d.
2 n.d. n.d. n.d. 1.38 ± 0.01 b 2.7 ± 0.1 a 1.22 ± 0.02 c 0.42 ± 0.01 d 0.290 ± 0.002 e 0.32 ± 0.01 e 0.297 ± 0.005 e 0.342 ± 0.001 e 0.064 ± 0.003 f 0.279 ± 0.002 e
0.058 ± 0.001
fg n.d. n.d.
3 n.d. n.d. n.d. 37.2 ± 0.3 a 33.9 ± 0.3 b 12.18 ± 0.05 fg 24.9 ± 0.4 c 19.2 ± 0.1 d 16.4 ± 0.2 e 11.64 ± 0.02 h 11.9 ± 0.2 gh 6.1 ± 0.1 k 8.7 ± 0.2 j 9.7 ± 0.1 i n.d. n.d.
4 3.6 ± 0.1 b 3.70 ± 0.03 b 5.4 ± 0.2 a n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 1.32 ± 0.03 d 2.02 ± 0.1 c
5 8.0 ± 0.2 c 8.65 ± 0.05 b 16.0 ± 0.5 a n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 2.524 ± 0.003 e 4.17 ± 0.04 d
6 n.d. n.d. n.d. 0.450 ± 0.001 d
0.4143 ± 0.0001
g 0.398 ± 0.001 h 0.598 ± 0.04 a 0.50 ± 0.01 e
0.451 ± 0.001
d 0.54 ± 0.01 b 0.43 ± 0.01 f 0.42 ± 0.01 fg 0.44 ± 0.01 r
0.444 ± 0.004
de n.d. n.d.
7 n.d. n.d. n.d. 0.80 ± 0.01 a 0.72 ± 0.01 b 0.61 ± 0.01 de 0.62 ± 0.01 cd 0.393 ± 0.003 g 0.60 ± 0.01 e 0.457 ± 0.004 f 0.348 ± 0.004 i 0.313 ± 0.005 j 0.631 ± 0.002 c 0.38 ± 0.01 h n.d. n.d.




h 0.589 ± 0.001 f 0.54 ± 0.01 g
0.5411 ±
0.0004 g n.d. n.d.
9 n.d. n.d. n.d. 0.471 ± 0.001 gh 0.41 ± 0.01 hi 0.395 ± 0.004 i 0.96 ± 0.05 e 0.49 ± 0.01 g 1.10 ± 0.02 d 1.26 ± 0.05 c 0.75 ± 0.01 f 0.76 ± 0.02 f 3.49 ± 0.02 a 2.6 ± 0.1 b n.d. n.d.
10 3.6 ± 0.1 a 1.29 ± 0.03 d 1.71 ± 0.02 b n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 1.02 ± 0.04 e 1.5 ± 0.1 c
11 30.1 ± 0.4 a 15.0 ± 0.1 e 13.1 ± 0.4 g 23.7 ± 0.4 b 8.4 ± 0.3 j 11.5 ± 0.3 h 16 ± 1 d 5.0 ± 0.1 l 12.9 ± 0.3 g 14.78 ± 0.02 ef 6.9 ± 0.2 k 5.42 ± 0.05 l 22 ± 1 c 13.1 ± 0.1 g 9.6 ± 0.2i 14.25 ± 0.03 f
12 2.4 ± 0.1 h 3.2 ± 0.1 f 3.5 ± 0.1 e 4.58 ± 0.02 c 1.63 ± 0.03 k 2.8 ± 0.1 g 3.03 ± 0.04 f 1.69 ± 0.01 k 3.6 ± 0.1 e 4.4 ± 0.1 d 1.60 ± 0.04 k 2.2 ± 0.1 i 6.3 ± 0.2 a 5.30 ± 0.02 b 1.54 ± 0.03k 1.90 ± 0.03 j
13 1.48 ± 0.01 d 3.05 ± 0.05 b 10.8 ± 0.1 a n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 2.01 ± 0.04c 1.27 ± 0.02 e
14 n.d. n.d. n.d. 1.08 ± 0.01 b 0.70 ± 0.01 g 0.62 ± 0.02 hi 1.16 ± 0.01 a 0.679 ± 0.002 g 0.94 ± 0.01 c 0.82 ± 0.04 e 0.59 ± 0.02 i 0.64 ± 0.02 h 0.763 ± 0.002 f 0.91 ± 0.02 d n.d. n.d.
15 n.d. n.d. n.d. 0.79 ± 0.02 a 0.457 ± 0.004 e 0.54 ± 0.03 d 0.38 ± 0.01 f 0.29 ± 0.01 g 0.63 ± 0.0 2 b 0.45 ± 0.02 e
0.4788 ±
0.0003 e 0.30 ± 0.01
g 0.7895 ±
0.0003 a 0.57 ± 0.02
c n.d. n.d.
TPA 47.8 ± 0.3 c 31.8 ± 0.2 h 40 ± 1 e 69.7 ± 0. 1 a 48.6 ± 0.4 b 29.3 ± 0.5 i 46.1 ± 0.4 d 27.3 ± 0.2 j 34.9 ± 0.4 f 32.56 ± 0.04 g 21.9 ± 0.4 l 14.9 ± 0.2 n 39.5 ± 0.2 e 29.6 ± 0.2 i 16.1 ± 0.2 m 23.85 ± 0.03 l
TF 1.48 ± 0.01 k 3.05 ± 0.05 f 10.8 ± 0.1 a 3.59 ± 0.01 d 2.211 ± 0.003 i 2.10 ± 0.01 ij 3.7 ± 0.1 d 2.55 ± 0.05 g 3.4 ± 0.1 e 3.4 ± 0.1 e 2.202 ± 0.005 i
2.407 ± 0.001
h 5.241 ± 0.003 b 4.5 ± 0.1 c 2.01 ± 0.04 j 1.27 ± 0.02 l
TPC 98.5 ± 0.6 b 69.7 ± 0.3 d 101 ± 1 a 73.3 ± 0.1 c 50.8 ± 0.4 e 31.4 ± 0.5 k 49.8 ± 0.3 f 29.8 ± 0.1 l 38.3 ± 0.3 h 33.9 ± 0.1 i 24.08 ± 0.39 m 17.3 ± 0.2 n 44.8 ± 0.2 g 34.1 ± 0.3 j 36.2 ± 0.5 l 50.2 ± 0.1 ef
Yield
(%) 25.46 27.4 30.99 30.9 34.79 39.36 33.53 37.56 22.86 30.98 20.17 15.46 14.42 11.90 14.4 14.57
Results are presented as the mean ± standard deviation. Different letters in the same row correspond to significant differences (p < 0.05). n.d.: not detected. The information regarding the calibration curves used
for quantification is described in Section 2.3. of the Material and Methods section. TPA: total phenolic acids (sum of the amounts of compounds 1, 2, 3, 4, 5, 7, 10, 11, 12, and 15); TF: total flavonoids (sum of the
amounts of compounds 6, 8, 9, 13, and 14); and TPC: total phenolic compounds (sum of the amounts of all fifteen compounds).
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Figure 2. Representation of the four major phenolic compounds found in the cardoon samples studied—namely, two 
phenolic acids (5-O-caffeoylquinic-(A) and 1,5-di-O-caffeoylquinic acids-(B)) and two flavonoids (luteolin-O-hexuro-
noside–(C) and luteolin-O-malonyl-hexoside-(D)). 
5-O-Caffeoylquinic (peak 3) and 1,5-O-Dicafffeoylquinic acids (peak 11) were the 
phenolic compounds present in higher abundance throughout the studied maturation 
stages (6.1–37.2 and 5.03–30.1-mg/g extract, respectively) (Table 2). Samples of immature 
petioles (samples P1–4) are those at which higher contents of phenolic compounds were 
determined (69.7–101-mg/g extract), especially sample P3 (101-mg/g extract), which refers 
to the early stage of PGS 2. Many of the identified compounds were not found in the pet-
iole samples harvested at the senescence (samples P15 and P16) and the early growth 
stages (samples P1–3). Only six of the identified phenolic compounds were detected in 
these samples (mostly derived from caffeoylquinic and dicaffeoylquinic acids). Moreover, 
differences in the extraction yields were observed between the tested samples (Table 2), 
with samples at the late maturity stages (P12–P16) showing the lowest extraction yield. 
This finding could be associated with the lignification that takes places at late maturity, 
which could make less effective the tested protocols in the polyphenol extractions [37,38]. 
Therefore, the results of this study showed that harvesting time has an influence on the 
phenolic content and composition in petioles. Although several reports have already 
proven that the stage of maturity influences the phenolic composition of different plant 
tissues of cardoons (flower heads, bracts, and receptacle), to the best of our knowledge, 
none of these studies has analyzed the phenolic composition of the petioles throughout 
the growth cycle. 
Mandim et al. [10] analyzed cardoon bracts harvested in different maturation stages, 
identifying twelve phenolic compounds, with 3,5-di-O-caffeoylquinic acid and apigenin-
7-O-glucuronide as the most abundant ones and immature bracts showing the highest 
content of total phenolics (29.73-mg/g extract). Additionally, the phenolic composition of 
cardoon capitulum varies throughout the plant’s growth cycle, with the youngest tissues 
presenting higher amounts of phenolic compounds (34.3-mg/g extract) [22]. By contrast, 
the receptacle showed an increase in the contents of phenolic compounds in the months 
of February, March, and April [39]. It was suggested that the variation in the phenolic 
content is related to the translocation of the compounds to parts of the plant with the 
highest biosynthetic activity at a given time [22]. Additionally, aspects such as growing 
location and conditions, variety, and post-harvest storage have an influence on the con-
tents of phenolic compounds [21,30,33]. The study of the influence of all these factors is 
extremely useful and important for the proper use and the economic value of the species. 
The obtained results could contribute useful information regarding the valorization of the 
cardoon petioles, which represent a high portion of plant biomass throughout its growth 
cycle. Therefore, harvests at specific growth stages could allow the obtainment of extracts 
with a high content in targeted compounds that could be used for pharmaceutical and 
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tissues of cardoons (flo er heads, bracts, and receptacle), to the best of our kno ledge,
none of these studies has analyzed the phenolic composition of the petioles throughout the
growth cycle.
Mandim et al. [10] analyzed cardoon bracts harvested in different maturation stages,
identifying twelve phenolic compounds, with 3,5-di-O-caffeoylquinic acid and apigenin-
7-O-glucuronide as the most abundant ones and immature bracts showing the highest
content of total phenolics (29.73-mg/g extract). Additionally, the phenolic composition of
cardoon capitulum varies throughout the plant’s growth cycle, with the youngest tissues
presenting higher amounts of phenolic compounds (34.3-mg/g extract) [22]. By contrast,
the receptacle showed an increase in the contents of phenolic compounds in the months of
February, March, and April [39]. It was suggested that the variation in the phenolic content
is related to the translocation of the compounds to parts of the plant with the highest
biosynthetic activity at a given time [22]. Additionally, aspects such as growing location
and conditions, variety, and post-harvest storage have an influence on the contents of
phenolic compounds [21,30,33]. The study of the influence of all these factors is extremely
useful and important for the proper use and the economic value of the species. The obtained
results could contribute useful information regarding the valorization of the cardoon petioles,
which represent a high portion of plant biomass throughout its growth cycle. Therefore,
harvests at specific growth stages could allow the obtainment of extracts with a high content
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in targeted compounds that could be used for pharmaceutical and nutraceutical purposes or
in the food industry for the production of healthy and functional foods.
3.2. Bioactive Properties
3.2.1. Antioxidant Potential
The antioxidant activity of the hydroethanolic extracts of cardoon petioles was studied
using two cell-based methodologies (TBARS and OxHLIA), and the obtained results are
presented in Table 3. All the analyzed samples exhibited the ability to inhibit the oxidation
process in both cell-based assays performed. For the TBARS assay, the samples in the early
maturation stages revealed, in general, lower IC50 values (i.e., more potent antioxidant
activity); in particular, sample P3 (PSG 1), with the highest phenolic content among the
analyzed samples, showed the highest antioxidant activity, with an IC50 value lower than
the positive control Trolox (IC50 value of sample P3: 5.0 µg/mL; Trolox: 9.1 µg/mL).
Table 3. Antioxidant activity of the hydroethanolic extracts of cardoon petioles.
Antioxidant Activity (IC50, µg/mL)
Sample TBARS OxHLIA(∆t = 60 min)
OxHLIA
(∆t = 120 min)
P1 15.8 ± 0.1 m 244 ± 5 b 323 ± 7 e
P2 22.6 ± 0.4 j 392 ± 10 a 563 ± 17 a
P3 5.0 ± 0.1 o 386 ± 2 a 542 ± 7 a
P4 75.6 ± 0.5 d 65 ± 4 i 180 ± 3 h
P5 61.0 ± 0.5 e 110 ± 5 h 245 ± 7 fg
P6 20.3 ± 0.2 l 195 ± 5 d 382 ± 5 c
P7 20.8 ± 0.5 kl 224 ± 9 bc 466 ± 18 b
P8 56.6 ± 0.5 f 168 ± 4 e 370 ± 4 cd
P9 92 ± 1 b 122 ± 4 gh 206 ± 4 gh
P10 58 ± 2 f 122 ± 4 gh 206 ± 4 gh
P11 83.9 ± 0.4 c 157 ± 6 e 289 ± 9 ef
P12 34.5 ± 0.5 h 135 ± 5 fg 266 ± 4 f
P13 27 ± 2 i 114 ± 2 gh 185 ± 4 h
P14 44.9 ± 0.5 g 102 ± 4 hj 201 ± 5 gh
P15 287 ± 2 a 208 ± 14 cd 400 ± 40 c
P16 21.9 ± 0.4 jk 150 ± 8 ef 243 ± 4 ef
Trolox 9.1 ± 0.3 n 21.2 ± 0.7 k 41.1 ± 0.8 i
Results are expressed as the mean ± standard deviation. Different letters in the same column correspond to
significant differences (p < 0.05). IC50 values correspond to the extract concentrations needed to inhibit 50% of the
formation of thiobarbituric acid reactive substances (TBARS), the oxidative hemolysis (OxHLIA).
On the other hand, sample P4, also at early maturity (PGS 2), was the most effective to
protect the erythrocytes from hemolysis (OxHLIA assay), showing the lowest IC50 values
compared with the remaining samples (IC50 values of 65 and 180 µg/mL for ∆t of 60 and
120 min, respectively). In contrast, the extracts of P15 (PSG 8/9) for TBARS and the P2 and
P3 (PSG 1) samples for OxHLIA were the ones with the highest IC50 values and, therefore,
with the lowest antioxidant activity.
The antioxidant potential in cardoon samples is one of the most-studied and described
bioactivities of the species, mainly using the radical-scavenging capacity through the DPPH
assay. The studies described in the literature verified that the antioxidant potential as-
sociated with this species depends on parameters such as the type and viability of the
plant tissue, the genetic information, and the maturity state [10,21,33,40]. In the present
study, the better antioxidant results in the TBARS assay were obtained in the samples
at early maturity coinciding with the highest content of phenolic compounds. With the
correlation study performed, it was possible to observe a negative correlation between
the phenolic content and both antioxidant activity assays performed, since the higher the
concentration of phenolic compounds, the lower the IC50 values (and, therefore, greater
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antioxidant activity). However, the R values were not very satisfactory, since phenolic acids
(R = −0.296), flavonoids (R = −0.260), and total compounds (R = −0.301) only explain,
approximately, 10% of the values obtained in the TBARS assay. In previous studies, a
negative correlation was confirmed between the total phenolic compounds and phenolic
acid content and high antioxidant activity as well [41,42]. Moreover, according to the study
of Pagano et al. [43], the antioxidant activities observed were mostly correlated with the
dicaffeoylquinic acid contents (−0.93 to −0.98 values for the Pearson’s coefficient), whereas
lower coefficient values (−0.5) were observed for the caffeoylquinic acids. This finding
could partly explain the findings of our study, where caffeoylquinic acids were the most
abundant phenolic compounds. However, the same was not verified for the OxHLIA
assay, pointing to other compounds that could be involved in the antioxidant capacity
as evaluated by this method, e.g., sesquiterpene lactones and inulin [44,45]. According
to the literature, the results regarding the correlation between the phenolic compound
contents and the antioxidant activity are contradictory and can be highly affected by the
extraction protocols and other parameters related to the genetic material and growing
conditions [32,46] or the plant part [33,38]. Moreover, the fact that this study evaluates
the antioxidant potential of petioles throughout the growth cycle is maybe another reason
that our results are in contrast with other reports and show weak correlations between the
phenolic compounds and antioxidant activity. Considering the variable chemical composi-
tions during the growth season, the correlation analysis did not allow us to obtain as high
Pearson’s coefficient values, as in the literature reports where a single harvest [33,41–43] or
a limited number of harvests were applied [10,22].
To the best of the authors’ knowledge, this is the first report regarding the antioxidant
activity of cardoon petioles collected throughout the growth cycle. In general, cardoon
petioles exhibited higher antioxidant potential than cardoon bracts and heads with the
same genetic information previously studied by our group [10,40].
3.2.2. Anti-Inflammatory Activity
The evaluation of the anti-inflammatory activity was performed through the measure-
ments of the capacity to inhibit the proinflammatory mediator NO by the LPS-stimulated
murine macrophage cell line (RAW 264.7). The obtained results are presented in Table 4.
All petiole extracts exhibited anti-inflammatory activity, except for samples P5, P6, and P7
(IC50 > 400 µg/mL). The anti-inflammatory activity of the cardoon petiole extracts varied
over the entire growth cycle, which suggests that the growing stage has an influence on
the anti-inflammatory potential. The sample collected at principal growth stage 5 (P9)
revealed the highest anti-inflammatory capacity, with an IC50 value of 14.2 µg/mL, which
was lower than the positive control dexamethasone (IC50 = 16 µg/mL). This finding further
supports our previous study regarding the correlation of antioxidant activity and phenolic
compound contents, since sample P9 did not contain the highest amount of any detected
phenolic compound, thus implying the presence of other bioactive compounds not detected
in our study.
Studies on the potential of cardoon as a source of compounds with anti-inflammatory
power are scarce. Contrary to what was observed for the petiole extracts, immature samples
of cardoon heads and bracts revealed the highest anti-inflammatory potential using the
same cell-based assay: heads IC50 = 72 µg/mL [22] and bracts IC50 = 183 µg/mL [10].
The ability of cardoon seeds to inhibit the production of NO was also studied, and none
of the extracts showed significant activity [40]. Petioles collected at principal growth
stage 7/8 have an interesting potential to be explored as sources of compounds with
anti-inflammatory potential, especially when considering that this stage refers to the late
stages of maturity, where plants are usually harvested for other purposes. To the best of the
authors’ knowledge, this is the first study that has assessed the anti-inflammatory potential
of cardoon petioles throughout plant maturation.
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Table 4. Anti-inflammatory activity of the hydroethanolic extracts of cardoon petioles.
Anti-Inflammatory Activity (IC50; µg/mL)
Sample RAW 246.7
P1 154 ± 4 d
P2 91 ± 2 e
P3 179 ± 3 c




P8 191 ± 10 b
P9 14.2 ± 0.5 h
P10 34 ± 4 g
P11 40 ± 2 g
P12 36 ± 2 g
P13 18 ± 2 h
P14 31 ± 1 g
P15 80 ± 3 f
P16 79 ± 3 f
Dexamethasone 16 ± 1 hi
Results are expressed as the mean ± standard deviation. Different letters in the same column correspond to
significant differences (p < 0.05). IC50 values correspond to the extract concentrations needed to inhibit 50% of the
nitric oxide (NO) production.
3.2.3. Cytotoxic Effects against Tumor and Nontumor Cells
The cytotoxic potential of cardoon petiole extracts is presented in Table 5. The results
are expressed as the extract concentrations that cause 50% of the cell proliferation inhibition
(GI50 values). According to the obtained results, the cytotoxic potential of the petiole
extracts not only depends on the growth stage but, also, on the employed type of cell lines.
HeLa is the cell line that presented the greatest susceptibility, with lower values of GI50
at almost all states of maturity, except for samples P1, P3, and P16 (Table 5). For these
samples, the HepG2 and MCF-7 cell lines were the most susceptible ones (lowest GI50
values). Samples at the mid-to-late maturation stages (especially sample P9) had greater
cytotoxic potential, in contrast to the samples harvested at the early growth stages (samples
P4–8) that presented higher GI50 values. In general, the GI50 values for the nontumor cells
(PLP2) were higher (i.e., lower cytotoxicity) than those obtained for the human tumor cell
lines. Considering our findings regarding the anti-inflammatory activity where sample P9
recorded the best performance among the tested samples, bioactive compounds other than
polyphenols should be acclaimed for the observed activities.
The study of the influence of the maturation stage on the cytotoxic potential of Cynara
cardunculus plant tissues has previously been studied in samples of bracts [10] and the capit-
ula (heads) [22]. In both studies, the younger stages of maturation showed greater cytotoxic,
contrary to what was observed for the petiole extracts. As previously noticed [21,40], in
addition to the stage of maturity and plant tissue, the bioactive potential may also be
influenced by factors such as the genetic information, growing location, and tissue viability.
To the best of the authors’ knowledge, the influence of the maturity stage on the cytotoxic
potential of the cardoon petioles has not yet been described in the literature.
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Table 5. Cytotoxic activity of the hydroethanolic extracts of cardoon petioles.
Cytotoxic Activity (GI50; µg/mL)
Sample MCF-7 NCI-H460 HeLa HepG2 PLP2
P1 150 ± 3 d 173 ± 14 d 153 ± 6 d 155 ± 9 d 239 ± 16 d
P2 76 ± 1 e 80 ± 6 e 58 ± 5 g 65 ± 4 e 143 ± 7 d
P3 191 ± 4 c 223 ± 7 c 141 ± 8 de 68 ± 2 e 336 ± 11 a
P4 253 ± 5 b 238 ± 23 c 132 ± 5 e 228 ± 9 c 307 ± 9 b
P5 >400 353 ± 25 a 20 ± 2 c 351 ± 14 a >400
P6 >400 >400 204 ± 15 a >400 314 ± 19 b
P7 345 ± 20 a >400 269 ± 8 b >400 >400
P8 203 ± 15 c 312 ± 8 b 82 ± 3 f 304 ± 11 b 282 ± 12 c
P9 12 ± 1 ij 16.0 ± 0.5 hi 11.1 ± 0.3 i 14 ± 1 g 16 ± 1 i
P10 43 ± 2 h 36 ± 2 gh 17 ± 1 i 17 ± 2 g 49 ± 3 jk
P11 58 ± 4 fg 55 ± 1 fg 38 ± 2 h 62 ± 5 e 61 ± 2 j
P12 26 ± 1 i 35 ± 1 gh 19 ± 1 i 16 ± 1 g 44 ± 1 jk
P13 23 ± 1 i 70 ± 1 ef 17 ± 1 i 19 ± 2 g 37 ± 1 h
P14 51 ± 3 gh 30 ± 2 h 20 ± 1 i 19 ± 2 g 55 ± 1 j
P15 66 ± 5 ef 86 ± 3 e 54 ± 3 gh 47 ± 4 f 112 ± 4 e
P16 60 ± 2 fg 72 ± 5 ef 55 ± 3 gh 39 ± 3 f 116 ± 6 e
Ellipticine 1.21 ± 0.02 k 0.9 ± 0.1 j 1.03 ± 0.09 j 1.10 ± 0.09 h 2.3 ± 0.2 j
Results are expressed as the mean ± standard deviation. Different letters in the same column correspond to
significant differences (p < 0.05). GI50 values correspond to the extract concentrations that cause 50% of the cell
growth inhibition.
3.2.4. Antimicrobial Activity
The results obtained in the antibacterial assessment of the cardoon petioles are pre-
sented in Table 6. All the tested extracts revealed the capacity to inhibit the bacterial
growth; in general, the Gram-positive bacteria revealed a higher susceptibility than the
Gram-negative. These results are in agreement with previous reports, due to a greater sus-
ceptibility of Gram-positive bacteria as a result of their membrane constitution [10,22,47].
In general, petioles at principal growth stage 3 (sample P5) showed higher antibacterial
activity, with lower MIC values for all the bacteria tested (MIC values between 0.75 and
1.51 mg/mL), even though the effectiveness varied greatly in the different types of bac-
teria studied. While the early maturation states (samples P2 and P3) showed a lower
potential against the bacteria Bacillus cereus, Escherichia coli, and Salmonella Typhimurium
(MIC values between 2.31 and 4.78 mg/mL), sample P4 (PSG 2) was the least effective
against Staphylococcus aureus (MIC values of 6.84 mg/mL), sample P16 showed a low
effectiveness against Listeria monocytogenes (MIC values of 4.73 mg/mL), and samples
P11–13 were the least effective against Enterobacter cloacae (MIC values between 3.24 and
3.63 mg/mL). Sample P7 (PSG 3/4) also demonstrated an interesting effectiveness against
Escherichia coli and Salmonella Typhimurium (MIC values between 0.78 and 1.57 mg/mL).
Gram-positive Bacillus cereus was the more susceptible bacteria (MIC values between 0.75
and 2.39 mg/mL). On the other hand, Staphylococcus aureus was the bacteria that revealed
higher MIC values and, therefore, lower susceptibility (MIC values between 1.51 and
6.84 mg/mL). Nevertheless, none of the tested extracts presented higher activity than the
positive controls used (i.e., commercial antibiotics streptomycin and ampicillin).
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Table 6. Antibacterial activity of the hydroethanolic extracts of the cardoon petioles.
Antibacterial Activity (mg/mL)
B. cereus S. aureus L.monocytogenes E. cloacae E. coli S.Typhimurium
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC
P1 1.17 2.33 2.33 4.66 2.33 4.66 2.33 4.66 2.33 4.66 2.33 4.66
P2 2.39 4.78 4.78 9.55 4.78 9.55 1.15 2.31 2.39 4.78 4.78 9.55
P3 2.31 4.61 4.61 9.23 2.31 4.61 4.61 9.23 4.61 9.23 4.61 9.23
P4 1.71 3.42 6.84 6.84 3.42 6.84 1.71 3.42 1.71 3.42 3.42 6.84
P5 0.75 1.51 1.51 3.02 1.51 3.02 1.51 3.02 0.75 1.51 1.51 3.02
P6 1.69 3.37 3.37 6.75 1.69 6.75 3.37 6.75 1.69 3.37 6.75 >6.75
P7 1.57 3.13 3.13 6.27 1.57 3.13 1.57 3.13 0.78 1.57 1.57 3.13
P8 1.63 3.27 1.63 3.27 1.63 3.27 1.63 3.27 0.82 1.63 1.63 3.27
P9 1.89 3.78 1.89 3.78 1.89 3.78 1.89 3.78 0.94 1.89 1.89 3.78
P10 1.78 3.55 3.55 7.11 1.78 3.55 1.78 3.55 1.78 3.55 3.55 7.11
P11 1.81 1.81 3.63 7.26 3.63 7.26 3.63 7.26 1.81 3.63 3.63 7.26
P12 0.81 1.62 3.24 6.48 3.24 6.48 3.24 6.48 3.24 6.48 3.24 6.48
P13 1.72 1.72 3.43 3.43 3.43 6.87 3.43 6.87 3.43 6.87 3.43 6.87
P14 0.85 1.71 1.71 3.42 1.71 3.42 1.71 3.42 1.71 3.42 1.71 3.42
P15 1.15 2.31 2.31 4.61 2.31 4.61 2.31 4.61 2.31 4.61 2.31 4.61
P16 1.18 2.36 4.73 9.46 4.73 9.76 2.36 4.73 2.36 4.73 2.36 4.73
Streptomycin 0.10 0.20 0.04 0.10 0.20 0.30 0.20 0.30 0.20 0.30 0.20 0.30
Ampicillin 0.25 0.40 0.25 0.45 0.40 0.50 0.25 0.50 0.40 0.50 0.75 1.20
MIC: minimal inhibitory concentration; MBC: minimal bactericidal concentration. Positive control: streptomycin and ampicillin.
Cardoon petioles presented higher antibacterial activity than other plant tissues of
cardoons previously studied, namely heads [22], bracts [10], viable and nonviable seeds
harvested in Viseu, Portugal [40], and inflorescences from different genotypes [21]. These
results further evidenced the influence that the different plant tissues, genetic information,
growing location, and maturation stage of the species may have on its bioactive potential.
Moreover, as mentioned in the case of the anti-inflammatory and cytotoxic activities, the
phenolic profiles of the best-performing samples (P2 and P5) did not justify a correlation
between the phenolic compound contents and the antibacterial activities of the cardoon
petioles, and other bioactive compounds should be implicated.
The antifungal potential of the cardoon petioles collected at different maturation
states was also analyzed, and the results are presented in Table 7. The antifungal potential
changed depending on the fungi tested. In general, samples with mid-to-late matura-
tions stages were more effective—namely, samples P10 and P11 against the fungi strains
Penicillium funiculosum, Penicillium ochrochloron, and Penicillium verrucosum var. cyclopium
(MIC values between 0.30 and 0.91 mg/mL). Sample P10 (PSG 5/6) presented lower MIC
values than the positive control used (commercial antifungal ketoconazole). Sample P14
showed a higher efficiency against Aspergillus fumigatus (MIC value of 0.28 mg/mL). The
sample collected at early maturity (sample P5) was the one with the highest antifungal
capacity against Aspergillus versicolor (MIC value of 0.50 mg/mL). On the other hand, peti-
oles harvested at the early maturation stages (samples P1–3) had less antifungal potential,
particularly against Aspergillus fumigatus, Aspergillus versicolor, and Penicillium ochrochloron
(MIC values between 0.92 and 3.71 mg/mL). For the remaining tested fungi strains (As-
pergillus niger, Penicillium funiculosum, and Penicillium verrucosum var. cyclopium), petioles at
lower maturity levels (samples P2–P5) revealed the highest MIC values and, therefore, the
lowest antifungal potential. Previous works have already proven the antifungal potential
of cardoon. It was verified that the maturity stage of cardoon heads and bracts had an
influence on the antifungal potential [10,22] but, also, the genetic information [21] and the
plant tissue [10,22,40]. The variable activities of the studied samples against the tested
fungi imply that bioactive compounds other than polyphenols should be implicated in the
observed antifungal properties of cardoon petioles.
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Table 7. Antifungal activity of the hydroethanolic extracts of cardoon petioles.
Antifungal Activity (mg/mL)
A. fumigatus A. versicolor A. niger P. funiculosum P. ochrochloron P. verrucosumvar. cyclopium
MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC
P1 3.71 7.42 1.86 3.71 1.86 3.71 0.93 1.86 1.86 3.71 1.86 3.71
P2 1.83 3.66 1.83 3.66 3.66 7.39 0.92 1.83 0.92 1.83 0.92 1.83
P3 3.71 7.42 0.93 1.86 1.86 3.71 0.93 1.86 3.71 7.42 1.86 3.71
P4 1.14 2.28 0.57 1.14 >9.12 > 9.12 0.57 1.14 0.57 1.14 0.57 1.14
P5 1.01 2.01 0.50 1.01 >8.05 >8.05 >8.05 >8.05 1.01 2.01 >8.05 >8.05
P6 1.12 2.25 1.12 2.25 >9 >9 >9 >9 5.62 1.12 9 >9
P7 0.52 1.04 0.52 1.04 >8.36 >8.36 0.52 1.04 0.52 1.04 1.04 2.09
P8 2.18 4.36 1.09 2.18 1.09 2.18 0.54 1.09 0.54 1.09 0.54 1.09
P9 2.52 5.04 1.26 2.52 1.26 2.52 1.26 2.52 1.26 2.52 0.63 1.26
P10 2.37 4.74 1.18 2.37 1.18 2.37 0.59 1.18 0.30 0.59 0.30 0.59
P11 0.91 1.81 0.91 1.81 1.81 3.63 0.45 0.91 0.91 1.81 0.45 0.91
P12 0.54 1.08 0.54 1.08 0.54 1.08 1.08 2.16 1.08 2.16 1.08 2.16
P13 0.57 1.14 1.14 2.29 1.14 2.29 0.57 1.14 0.57 1.14 0.57 1.14
P14 0.28 0.57 0.57 1.14 1.14 2.28 0.57 1.14 1.14 2.28 0.57 2.28
P15 0.90 1.80 1.80 3.60 3.60 7.18 1.80 3.60 0.90 1.80 1.80 3.60
P16 3.64 7.28 0.91 1.82 1.82 3.64 0.91 1.82 1.82 3.64 0.91 1.82
Ketoconazole 0.25 0.50 0.20 0.50 0.20 0.50 0.20 0.50 1.00 1.50 0.20 0.30
MIC: minimal inhibitory concentration; MFC: minimal fungicidal concentration. Positive control: ketoconazole.
3.3. Principal Component Analysis (PCA)
The principal component analysis (PCA) is used to reduce the complexity of multi-
variate data as a means of identifying specific patterns and expressing data in ways that
highlight similarities and differences and, further, visualize groups of samples according to
their maturation stage [48,49]. The first seven principal components (PCs) were associated
with Eigen values higher than 1 and explained 91.74% of the cumulative variance, with
PC1 accounting for 39.51%, PC2 for 17.62%, PC3 for 11.91%, PC4 for 7.39%, PC5 for 6.71%,
PC6 for 4.54%, and finally, PC7 for 4.06%. For simplification reasons, only the first three
PCAs will be considered, since they added more than 10% to the cumulative variance,
up to a total of 66.23%. PC1 was positively correlated with phenolic compounds with
peak numbers 4, 5, 6, and 13 and total phenolic compounds PLP2 and OxHLIA ∆t60
and negatively correlated with TBARS and phenolic compounds with peak numbers 7,
8, 14, and 15 and malic and citric acids. PC2 was only negatively correlated with the
phenolic compound with peak number 3, total phenolic acids, total phenolic compounds,
HepG2, MCF-7, RAW264.7, PLP2, oxalic acid, quinic acid, and total organic acid. PC3
was positively correlated with phenolic compounds with peak numbers 2 and 3, HepG2,
NCI-H460, and quinic acids and negatively correlated with phenolic compounds with peak
numbers 9 and 12 and the total flavonoids. These results indicated the correct application
of the PCA, allowing the differentiation of petiole samples between the tested maturity
stages, as shown in the corresponding scatterplot (Figure 3). Moreover, the presented plot
suggests that the differences in the chemical compositions and bioactive properties of the
tested petiole samples are correlated with the maturation stage. In particular, nine distinct
groups were detected consisting of samples P1 and P2; sample P3; sample P4; sample P5;
samples P6, P9, P10, and P14; samples P7 and P13; samples P8, 11, and 12; sample P15; and
sample P16. The early (samples P1–P5) and late maturity stages (samples P15 and P16) are
scattered in the scatterplot, whereas the intermedium maturity stages (samples P6–P14) are
closely located. The loading plot (Figure 4) of the first two components revealed groups
of positively correlated variables—namely, the upper-left quadrant comprising malic acid
and the phenolic compound with peak number 9; the lower-left quadrant comprising
phenolic compounds with peak numbers 1, 3, 6, 7, 8, 14, and 15; TPA; and citric acid; and
Antioxidants 2021, 10, 1907 16 of 19
the lower-right quadrant comprising phenolic compounds with peak numbers 4, 5, 10, and
13; oxalic acid; TPC; RAW264.7; NCI-H460; OxHLIA ∆t60; and OxHLIA ∆t120.
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4. Conclusions
According to the obtained results, the phenolic compositions and biological prop-
erties of the cardoon petioles were influenced by the maturation stage. The samples at
the early maturation stages (sample P3) revealed higher levels of phenolic c mpounds,
especially 5-O-caffeoylquinic and 1,5-O-dicafffeoylquinic acids, which were detected in
higher abundance. The sample P3 collected at early maturity also exhibited the highest
capacity to inhibit the lipid peroxidation through TBARS formation inhibition, which could
be attributed to the overall amounts of the phenolic compounds and/or the high contents
in the 5-O-caffeoylquinic and 1,5-O-dicafffeoylquinic acids. In contrast, the samples at the
mid-to-late maturation stages revealed the highest anti-inflammatory (sample P13) and
cytotoxic (samples P7–P13) potential. A sample collected at the early stages (sample P4)
exhibited the higher capacity to inhibit oxidative hemolysis and the bacterial growth, which
could be associated with the highest content in total phenolic acids and 4-O-caffeoylquinic
acid in particular. Regarding the antifungal potential, the tested extracts exhibited distinct
behaviors against the fungi strains tested; while the samples at the intermediate maturation
stages presented higher potential against Penicillium funiculosum, Penicillium ochrochloron,
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Penicillium verrucosum var. cyclopium, and Aspergillus fumigatus, the immature sample P5
was the most effective against Aspergillus versicolor. The fact that the samples at intermedi-
ate maturity did not contain high amounts of polyphenols indicates that other compounds
not detected in the present study could be responsible for these activities. Considering that
cardoon petioles are one of the less-explored and used tissues of this plant, collecting these
valuable plant tissues at the proper maturity stages could help to obtain natural matrices
with specific bioactive compounds and corresponding end uses. Moreover, an in-depth
characterization in terms of the phenolic composition and bioactive properties will further
contribute to the proper valorization of the species and its exploitation by different sectors.
In conclusion, the association of the observed bioactive properties with individual com-
pounds could allow harvests at specific growth stages aiming to obtain extracts with high
contents in targeted compounds that could be used in the pharmaceutical, nutraceutical, or
in the food industries.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/antiox10121907/s1: SM1. Exemplificative phenolic profiles of the sixteen samples of cardoons
studied recorded at 280 nm. SM2. MS2 (1) and MS3 (2) spectra of the dicaffeoylquinic acid isomers
found in petioles samples of cardoon: A1/A2-1,3-di-O-caffeoylquinic acid, B1/B2: O-dicaffeoylquinic
acid, C1/C2: 1,5-di-O-cafffeoylquinic acid, D1/D2: 3,4-di-O-cafffeoylquinic acid, and E1/E2: 3,5-di-
O-caffeolyquinic acid.
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Buelga, C.; et al. Seasonal variation of bioactive properties and phenolic composition of Cynara cardunculus var. altilis. Food Res.
Int. 2020, 134, 109281. [CrossRef]
23. Ongaro, A.; Povolo, C.; Zagotto, G.; Ribaudo, G. HPLC and NMR quantification of bioactive compounds in flowers and leaves of
Brassica rapa: The influence of aging. Nat. Prod. Res. 2019, 34, 1288–1291. [CrossRef] [PubMed]
24. Mandim, F.; Petropoulos, S.A.; Fernandes, Â.; Santos-Buelga, C.; Ferreira, I.C.F.R.; Barros, L. Chemical Composition of Cynara
Cardunculus, L. var. altilis Heads: The Impact of Harvesting Time. Agronomy 2020, 10, 1088. [CrossRef]
25. Petropoulos, S.; Fernandes, Â.; Karkanis, A.; Ntatsi, G.; Barros, L.; Ferreira, I.C. Successive harvesting affects yield, chemical
composition and antioxidant activity of Cichorium spinosum L. Food Chem. 2017, 237, 83–90. [CrossRef] [PubMed]
26. Petropoulos, S.; Fernandes, Â.; Barros, L.; Ferreira, I.C.F.R. Chemical composition, nutritional value and antioxidant properties of
Mediterranean okra genotypes in relation to harvest stage. Food Chem. 2018, 242, 466–474. [CrossRef]
27. Archontoulis, S.V.; Struik, P.C.; Vos, J.; Danalatos, N.G. Phenological growth stages of Cynara cardunculus: Codification and
description according to the BBCH scale. Ann. Appl. Biol. 2010, 156, 253–270. [CrossRef]
28. Bessada, S.; Barreira, J.; Barros, L.; Ferreira, I.C.; Oliveira, B. Phenolic profile and antioxidant activity of Coleostephus myconis (L.)
Rchb.f.: An underexploited and highly disseminated species. Ind. Crop. Prod. 2016, 89, 45–51. [CrossRef]
29. Mandim, F.; Barros, L.; Calhelha, R.C.; Abreu, R.M.V.; Pinela, J.; Alves, M.J.; Heleno, S.; Santos, P.F.; Ferreira, I.C.F.R. Calluna
vulgaris (L.) Hull: Chemical characterization, evaluation of its bioactive properties and effect on the vaginal microbiota. Food
Funct. 2019, 10, 78–89. [CrossRef] [PubMed]
30. Petropoulos, S.A.; Fernandes, Â.; Tzortzakis, N.; Sokovic, M.; Ciric, A.; Barros, L.; Ferreira, I.C. Bioactive compounds content and
antimicrobial activities of wild edible Asteraceae species of the Mediterranean flora under commercial cultivation conditions.
Food Res. Int. 2019, 119, 859–868. [CrossRef]
31. Clifford, M.N.; Johnston, K.L.; Knight, S.; Kuhnert, N. Hierarchical scheme for LC-MSnidentification of chlorogenic acids. J. Agric.
Food Chem. 2003, 51, 2900–2911. [CrossRef]
Antioxidants 2021, 10, 1907 19 of 19
32. Clifford, M.N.; Knight, S.; Kuhnert, N. Discriminating between the Six Isomers of Dicaffeoylquinic Acid by LC-MSn. J. Agric.
Food Chem. 2005, 53, 3821–3832. [CrossRef]
33. Petropoulos, S.A.; Pereira, C.; Tzortzakis, N.; Barros, L.; Ferreira, I.C.F.R. Nutritional Value and Bioactive Compounds Char-
acterization of Plant Parts from Cynara cardunculus L. (Asteraceae) Cultivated in Central Greece. Front. Plant Sci. 2018, 9, 459.
[CrossRef]
34. Petropoulos, S.A.; Pereira, C.; Ntatsi, G.; Danalatos, N.; Barros, L.; Ferreira, I.C.F.R. Nutritional value and chemical composition
of Greek artichoke genotypes. Food Chem. 2018, 267, 296–302. [CrossRef] [PubMed]
35. Graça, V.; Barros, L.; Calhelha, R.C.; Dias, M.I.; Ferreira, I.C.F.R.; Santos, P. Bio-guided fractionation of extracts of Geranium
robertianum L.: Relationship between phenolic profile and biological activity. Ind. Crop. Prod. 2017, 108, 543–552. [CrossRef]
36. Shallan, M.A.; Ali, M.A.; Meshrf, W.A.; Marrez, D.A. In vitro antimicrobial, antioxidant and anticancer activities of globe
artichoke (Cynara cardunculus var. scolymus L.) bracts and receptacles ethanolic extract. Biocatal. Agric. Biotechnol. 2020, 29, 101774.
[CrossRef]
37. Pandino, G.; Lombardo, S.; Mauromicale, G.; Williamson, G. Profile of polyphenols and phenolic acids in bracts and receptacles
of globe artichoke (Cynara cardunculus var. scolymus) germplasm. J. Food Compos. Anal. 2011, 24, 148–153. [CrossRef]
38. Graziani, G.; Docimo, T.; Palma, M.; Sparvoli, F.; Izzo, L.; Tucci, M.; Ritieni, A. Changes in Phenolics and Fatty Acids Composition
and Related Gene Expression during the Development from Seed to Leaves of Three Cultivated Cardoon Genotypes. Antioxidants
2020, 9, 1096. [CrossRef] [PubMed]
39. Pandino, G.; Lombardo, S.; Lo Monaco, A.; Mauromicale, G. Choice of time of harvest influences the polyphenol profile of globe
artichoke. J. Funct. Foods 2013, 5, 1822–1828. [CrossRef]
40. Mandim, F.; Dias, M.I.; Pinela, J.; Barracosa, P.; Ivanov, M.; Stojkovic, D.; Sokovic, M.; Santos-Buelga, C.; Barros, L.; Ferreira, I.C.F.R.
Chemical composition and in vitro biological activities of cardoon (Cynara cardunculus L. var. altilis DC.) seeds as influenced by
viability. Food Chem. 2020, 323, 126838. [CrossRef]
41. Piluzza, G.; Bullitta, S. Correlations between phenolic content and antioxidant properties in twenty-four plant species of traditional
ethnoveterinary use in the Mediterranean area. Pharm. Biol. 2011, 49, 240–247. [CrossRef]
42. Zheng, W.; Wang, S.Y. Antioxidant activity and phenolic compounds in selected herbs. J. Agric. Food Chem. 2001, 49, 5165–5170.
[CrossRef] [PubMed]
43. Pagano, I.; Piccinelli, A.L.; Celano, R.; Campone, L.; Gazzerro, P.; De Falco, E.; Rastrelli, L. Chemical profile and cellular
antioxidant activity of artichoke by-products. Food Funct. 2016, 7, 4841–4850. [CrossRef]
44. Docimo, T.; De Stefano, R.; Cappetta, E.; Piccinelli, A.L.; Celano, R.; De Palma, M.; Tucci, M. Physiological, Biochemical, and
Metabolic Responses to Short and Prolonged Saline Stress in Two Cultivated Cardoon Genotypes. Plants 2020, 9, 554. [CrossRef]
[PubMed]
45. Shang, H.M.; Zhou, H.Z.; Yang, J.Y.; Li, R.; Song, H.; Wu, H.X. In vitro and in vivo antioxidant activities of inulin. PLoS ONE
2018, 13, e0192273. [CrossRef]
46. Llorach, R.; Espín, J.C.; Tomás-Barberán, F.A.; Ferreres, F. Artichoke (Cynara scolymus L.) Byproducts as a Potential Source of
Health-Promoting Antioxidant Phenolics. J. Agric. Food Chem. 2002, 50, 3458–3464. [CrossRef] [PubMed]
47. Scavo, A.; Pandino, G.; Restuccia, C.; Parafati, L.; Cirvilleri, G.; Mauromicale, G. Antimicrobial activity of cultivated cardoon
(Cynara cardunculus L. var. altilis DC.) leaf extracts against bacterial species of agricultural and food interest. Ind. Crop. Prod. 2019,
129, 206–211. [CrossRef]
48. Petropoulos, S.A.; Pereira, C.; Barros, L.; Ferreira, I.C.F.R. Leaf parts from Greek artichoke genotypes as a good source of bioactive
compounds and antioxidants. Food Funct. 2017, 8, 2022–2029. [CrossRef] [PubMed]
49. El-Nakhel, C.; Petropoulos, S.A.; Pannico, A.; Kyriacou, M.C.; Giordano, M.; Colla, G.; Troise, A.D.; Vitaglione, P.; De Pascale,
S.; Rouphael, Y. The bioactive profile of lettuce produced in a closed soilless system as configured by combinatorial effects of
genotype and macrocation supply composition. Food Chem. 2019, 309, 125713. [CrossRef]
